Healthcare provider profile · identity verified

Patrick A Raney, MD

Allopathic & Osteopathic Physicians|Family Medicine · TOPEKA, KS · NPI 1821165861

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Patrick A Raney, MD received $47.81 in general payments during 2025 across 1 reported records.

Ascensia Diabetes Care Us Inc. accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$47.81

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Ascensia Diabetes Care Us Inc.	Unresolved — no canonical attribution shown	$47.81	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$47.81	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	619	178
Levothyroxine Sodium	Levothyroxine Sodium	555	134
Simvastatin	Simvastatin	437	117
Losartan Potassium	Losartan Potassium	415	111
Atorvastatin Calcium	Atorvastatin Calcium	405	104
Omeprazole	Omeprazole	396	102
Lisinopril	Lisinopril	345	102
Amlodipine Besylate	Amlodipine Besylate	328	86
Hydrochlorothiazide	Hydrochlorothiazide	321	92
Tamsulosin Hcl	Tamsulosin Hcl	256	64
Gabapentin	Gabapentin	219	58
Trazodone Hcl	Trazodone Hcl	206	59
Pantoprazole Sodium	Pantoprazole Sodium	202	62
Metformin Hcl Er	Metformin Hcl	184	52
Metoprolol Succinate	Metoprolol Succinate	171	42
Metformin Hcl	Metformin Hcl	158	36
Tramadol Hcl	Tramadol Hcl	143	51
Sertraline Hcl	Sertraline Hcl	139	38
Tizanidine Hcl	Tizanidine Hcl	123	54
Furosemide	Furosemide	117	39
Fluticasone Propionate	Fluticasone Propionate	112	32
Eliquis	Apixaban	108	23
Metoprolol Tartrate	Metoprolol Tartrate	106	28
Fenofibrate	Fenofibrate	100	26
Montelukast Sodium	Montelukast Sodium	98	26
Albuterol Sulfate Hfa	Albuterol Sulfate	97	38
Allopurinol	Allopurinol	97	24
Ezetimibe	Ezetimibe	94	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	92	19
Clopidogrel	Clopidogrel Bisulfate	91	25
Glipizide	Glipizide	91	24
Escitalopram Oxalate	Escitalopram Oxalate	89	22
Venlafaxine Hcl Er	Venlafaxine Hcl	79	18
Diclofenac Sodium	Diclofenac Sodium	78	36
Duloxetine Hcl	Duloxetine Hcl	78	29
Azelastine Hcl	Azelastine Hcl	73	34
Famotidine	Famotidine	66	19
Ozempic	Semaglutide	65	14
Atenolol	Atenolol	64	18
Potassium Chloride	Potassium Chloride	63	17
Fenofibrate	Fenofibrate Nanocrystallized	61	18
Fluoxetine Hcl	Fluoxetine Hcl	60	15
Incruse Ellipta	Umeclidinium Bromide	60	13
Alendronate Sodium	Alendronate Sodium	58	16
Finasteride	Finasteride	57	16
Farxiga	Dapagliflozin Propanediol	56	15
Pravastatin Sodium	Pravastatin Sodium	56	16
Jardiance	Empagliflozin	54	suppressed
Carvedilol	Carvedilol	53	12
Irbesartan	Irbesartan	51	14
Oxybutynin Chloride Er	Oxybutynin Chloride	48	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	38
Citalopram Hbr	Citalopram Hydrobromide	46	12
Doxazosin Mesylate	Doxazosin Mesylate	46	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	15
Ropinirole Hcl	Ropinirole Hcl	45	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	13
Pregabalin	Pregabalin	44	12
Eszopiclone	Eszopiclone	43	suppressed
Ondansetron Odt	Ondansetron	43	19
Paroxetine Hcl	Paroxetine Hcl	43	12
Warfarin Sodium	Warfarin Sodium	43	12
Aripiprazole	Aripiprazole	42	suppressed
Januvia	Sitagliptin Phosphate	42	suppressed
Glimepiride	Glimepiride	41	12
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	13
Pioglitazone Hcl	Pioglitazone Hcl	39	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Clonazepam	Clonazepam	37	12
Meloxicam	Meloxicam	35	12
Nystatin	Nystatin	35	13
Propranolol Hcl	Propranolol Hcl	35	12
Spiriva Respimat	Tiotropium Bromide	35	11
Dicyclomine Hcl	Dicyclomine Hcl	34	11
Prednisone	Prednisone	34	28
Celecoxib	Celecoxib	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	15
Synthroid	Levothyroxine Sodium	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Valsartan	Valsartan	31	11
Methocarbamol	Methocarbamol	30	suppressed
Terazosin Hcl	Terazosin Hcl	30	suppressed
Fluconazole	Fluconazole	29	13
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Azithromycin	Azithromycin	23	21
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Ramipril	Ramipril	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Fentanyl	Fentanyl	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Benazepril Hcl	Benazepril Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Colchicine	Colchicine	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Glycopyrrolate	Glycopyrrolate	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Baclofen	Baclofen	14	suppressed
Estradiol	Estradiol	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Low-Ogestrel	Norgestrel-Ethinyl Estradiol	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clonidine	Clonidine	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	11	suppressed
Ketoconazole	Ketoconazole	11	11
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Primidone	Primidone	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$47.81 · 1 records	Ascensia Diabetes Care Us Inc.	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error